(Q35793350)

10 August 2017

1 reference

title

Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients (English)

1 reference

10 August 2017

0 references

0 references

Malcolm Peet

1

1 reference

10 August 2017

Sandeep Shah

series ordinal

2

1 reference

10 August 2017

Karupiah Selvam

series ordinal

3

1 reference

10 August 2017

C N Ramchand

series ordinal

4

1 reference

10 August 2017

1 April 2004

1 reference

World Journal of Biological Psychiatry

10 August 2017

1 reference

10 August 2017

5

1 reference

10 August 2017

2

1 reference

10 August 2017

92-99

1 reference

Negative v positive schizophrenia. Definition and validation.

10 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Lipid peroxidation in erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Effects of dietary polyunsaturated fatty acids on neuronal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Fatty acid levels in the brains of schizophrenics and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Trifluoperazine increases fatty acid turnover in phospholipids in cultured human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Preface--fatty acids and cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Fatty acid profiles in mental disease. Part 1. Linolenate variations in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Chlorpromazine and carnitine-dependency of rat liver peroxisomal beta-oxidation of long-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Reliability of fatty acid composition in human serum phospholipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15622970410029917

10.1080/15622970410029917

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference